Contact
searchSearch
HMP Global

Advertisement

Publications

Specialty

Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
AliMed, Inc. Awarded Vizient Contract for Radiation Protection Products
09/04/2024
AliMed's contract covers an extensive range of radiation protection products, featuring off-the-shelf Grab 'n Go™ Aprons with same-day shipping and fully customizable Perfect Fit™ Aprons with tailored sizing and personalization options.
First Report Managed Care, Population Health
Streamlining Biosimilars: FDA's Draft Guidance Signals Big Changes (Part 2)
09/04/2024
This is a continuation of our Behind the Bill on the FDA’s new guidance for biosimilar interchangeability.
Advances in Inflammatory Bowel Disease Network
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
First Report Managed Care
Obesity's Dual Role in Abdominal Aortic Aneurysm: Risk Factor and Protective Paradox
09/03/2024
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of abdominal aortic aneurysm (AAA), according to a review published in Frontiers in Endocrinology.
EP Lab Digest
Asundexian Inferior to Apixaban for Stroke Prevention in Atrial Fibrillation
09/03/2024
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
EP Lab Digest
Edoxaban vs. Edoxaban Plus An Antiplatelet Agent in Patients With Atrial Fibrillation and Stable Coronary Artery Disease
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.1 The EPIC-CAD trial is simultaneously published in the New England Journal of Medicine. 
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
First U.S. Patient Randomized to CT-Guided PCI in P4 Research Trial Accelerating Innovation with Advanced Cardiovascular Imaging
09/03/2024
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollments in the Precise Procedural and PCI Plan (P4) Research Trial evaluating the potential for advanced cardiovascular imaging to enhance patient care.
EP Lab Digest
Village Doctors With Telemedicine Support Reduce Risk of Cardiovascular Death in Patients With Atrial Fibrillation by 50%
09/03/2024
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Telemedicine support to village doctors could hold the key to improving access to care for China’s rural elderly at risk for developing potentially life-threatening complications resulting from untreated atrial fibrillation, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept). 
First Report Managed Care
Stereotactic Magnetic Resonance (MR)-Guided Radiotherapy Shows Promise for Inoperable Upper Tract Urothelial Carcinoma
09/03/2024
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
EP Lab Digest
Results From the ESC’s First Randomised Trial Shows Education for Healthcare Professionals Can Improve Guideline Implementation
09/03/2024
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe, but a structured educational programme for healthcare professionals improved implementation of heart rhythm control recommendations in patients, according to late-breaking research presented in a Hot Line session today at the ESC Congress 2024.1 
EP Lab Digest
Mass Screening for Atrial Fibrillation Using ECG Together With Heart Failure Biomarker Does Not Prevent Stroke in Older Adults
09/03/2024
European Society of Cardiology Press Release
EP Lab Digest
Mainstay Ablation Procedure for Atrial Fibrillation Shows Substantial Benefit Over Sham Procedure
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements in symptoms and quality of life compared with a sham (placebo) procedure, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept).  
EP Lab Digest
Simplified Atrial Fibrillation Ablation Technique Benefits Heart Failure Patients
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, radiofrequency (RF) ablation, in heart failure patients with a reduced ejection fraction (HFrEF), according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept).  
EP Lab Digest
Widely Performed ‘Additional’ Ablation Procedure Targeting Diseased Heart Muscle Not Effective in Patients With Persistent Atrial Fibrillation
09/03/2024
European Society of Cardiology Press Release  Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AF) does not improve freedom from arrhythmias at 1 year.  However, in a subgroup of patients with left atrium enlargement, additional low voltage-area ablation reduced AF recurrence by 40%. 
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical’s DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of Action
09/03/2024
The INFINITY-SWEDEHEART Randomized Controlled Trial comparing the novel DynamX® Coronary Bioadaptor System with the contemporary Resolute Onyx™ zotarolimus drug-eluting stent (DES) met its primary endpoint of target lesion failure (TLF) non-inferiority (2.35% versus 2.77%; P
EP Lab Digest
Medtronic EV ICD Global Pivotal Trial Final Results Demonstrate High ATP Success and Effective Defibrillation: ESC Congress 2024
09/03/2024
Medtronic Press Release  Medtronic plc, a global leader in healthcare technology, shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. The results were presented as late-breaking clinical science at the ESC (European Society of Cardiology) Congress 2024 in London.
EP Lab Digest
DRAI MARTINI: Artificial Intelligence Beats Human Readers at Arrhythmia Detection
09/03/2024
European Society of Cardiology Press Release  WARSAW, Poland, Sept. 2, 2024 -- New research presented at the ESC Congress 2024 reveals that a novel artificial intelligence (AI) algorithm has significantly higher sensitivity than human specialists in detecting heart rhythm disorders on long ECG recordings. The DRAI MARTINI study tested the AI, finding that conventional methods using human technicians to read ECG led to missed diagnosis 14 times more often than when using artificial intelligence.
EP Lab Digest
Anthos Therapeutics Unveils Additional Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating that the Factor XI Inhibitor Abelacimab was Associated with Remarkably Low Levels of Periprocedural Bleeding in Patients with Atrial Fibrillation
09/03/2024
Anthos Therapeutics Press Release 
Oncology
Potential for Measurable Residual Disease as an End Point in Chronic Lymphocytic Leukemia Research
09/03/2024
Talal Hilal, MD, discusses an analysis on whether measurable residual disease can serve as a valuable end point in chronic lymphocytic leukemia clinical trials.
Neurology, Pharmacy Learning Network
Patients with Multiple Sclerosis Less Likely to Develop Alzheimer Disease
09/03/2024
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.

Advertisement

Subscribe and never miss an article!

Today's Wound Clinic Newsletter

Letter From the Editor

Guest Editorial
Advocate for Your Wound Care Patients on the Proposed MAC Policy on CTPs
05/29/2024
Eric J. Lullove, DPM, CWSP
The MACs recently released proposed coverage policy updates for applying CTPs for DFUs and VLUs. This is your opportunity to effect change by submitting comments to the MACs before the policy becomes final. You have a responsibility to know...
The MACs recently released proposed coverage policy updates for applying CTPs for DFUs and VLUs. This is your opportunity to effect change by submitting comments to the MACs before the policy becomes final. You have a responsibility to know...
The MACs recently released...
05/29/2024
Today's Wound Clinic
From the Editor
The Future of Wound Care in the Quality Payment Program
03/13/2024
Whether we will be able to survive as wound care practitioners will, at least in part, depend on having quality measures that are relevant to what we actually do.
Whether we will be able to survive as wound care practitioners will, at least in part, depend on having quality measures that are relevant to what we actually do.
Whether we will be able to...
03/13/2024
Today's Wound Clinic
From the Editor
The Non-Pressure Ulcer Episode-Based Cost Measure "Field Test" Began Feb. 1
02/05/2024
For years I have been explaining how the QPP could be the end of wound care practitioners. The entire QPP is designed around recognized medical specialties and since there is no recognized specialty for wound care, we are all in trouble.
For years I have been explaining how the QPP could be the end of wound care practitioners. The entire QPP is designed around recognized medical specialties and since there is no recognized specialty for wound care, we are all in trouble.
For years I have been explaining...
02/05/2024
Today's Wound Clinic
Guest Editorial
The G-Code Solution to Skin Substitute Reimbursement
01/25/2024
I am calling on CMS to adopt new G codes to replace Q code reimbursement and CPT 15000 codes for skin substitute application procedures and to establish skin substitute product code classes.
I am calling on CMS to adopt new G codes to replace Q code reimbursement and CPT 15000 codes for skin substitute application procedures and to establish skin substitute product code classes.
I am calling on CMS to adopt new...
01/25/2024
Today's Wound Clinic
Guest Editorial
Wound Size Matters: Analysis of the New Restrictive Skin Substitute LCD Policy
09/01/2023
With so much ambiguity remaining, an immediate compromise on the number of applications to allow 7 is warranted both from an ethical and medical perspective. The current restriction of 4 applications is clearly not based on an accurate...
With so much ambiguity remaining, an immediate compromise on the number of applications to allow 7 is warranted both from an ethical and medical perspective. The current restriction of 4 applications is clearly not based on an accurate...
With so much ambiguity...
09/01/2023
Today's Wound Clinic
Guest Editorial
Wrestling With Implicit Bias to Deliver Better Care for Our Patients
06/01/2023
For some, bias remains a sensitive issue, and some people are reluctant to admit to the need for introspection. However, to mitigate the ill effects of bias, everyone must first acknowledge that it exists.
For some, bias remains a sensitive issue, and some people are reluctant to admit to the need for introspection. However, to mitigate the ill effects of bias, everyone must first acknowledge that it exists.
For some, bias remains a...
06/01/2023
Today's Wound Clinic
From the Editor
Confessions of a Doctor With Lipedema
03/14/2023
It is hard to understand how demoralizing it is. Lipedema affects your entire life, starting in the teenage years.
It is hard to understand how demoralizing it is. Lipedema affects your entire life, starting in the teenage years.
It is hard to understand how...
03/14/2023
Today's Wound Clinic
From the Editor
Why Won’t the DME Provide Dressings for My Patient?
02/23/2023
Maybe Because Of My Documentation
Maybe Because Of My Documentation
Maybe Because Of My...
02/23/2023
Today's Wound Clinic
Guest Editorial
How Wound Care Providers Can Treat Patients Like People, Not Like Cases
02/01/2023
Finding a skilled wound care professional comes down finding someone who is confident in their skill/craft—someone who treats the whole patient, not just the wound. Finding someone who would see me as a person and a whole being rather than...
Finding a skilled wound care professional comes down finding someone who is confident in their skill/craft—someone who treats the whole patient, not just the wound. Finding someone who would see me as a person and a whole being rather than...
Finding a skilled wound care...
02/01/2023
Today's Wound Clinic
Guest Editorial
Amputations in Pyoderma Gangrenosum Patients: Underreported or Very Rare?
01/11/2023
Are providers missing the diagnosis of PG because they are anchoring on “positive” biopsy findings? Could we be missing cases in which PG patients underwent amputation, didn’t have a recurrence, and were never diagnosed? Or are we just not...
Are providers missing the diagnosis of PG because they are anchoring on “positive” biopsy findings? Could we be missing cases in which PG patients underwent amputation, didn’t have a recurrence, and were never diagnosed? Or are we just not...
Are providers missing the...
01/11/2023
Today's Wound Clinic

Advertisement

Coping With COVID-19

Business Briefs
Telehealth Use Continues and Receives Further Medicare Payment 
01/25/2023
The COVID-19 PHE has been extended for 90 more days. This author reviews the Medicare telehealth flexibility extensions that may be important to wound/ulcer management professionals.
The COVID-19 PHE has been extended for 90 more days. This author reviews the Medicare telehealth flexibility extensions that may be important to wound/ulcer management professionals.
The COVID-19 PHE has been...
01/25/2023
Today's Wound Clinic
Business Briefs
The COVID-19 Public Health Emergency Waivers Q&A
09/07/2022
This author answers more questions about what will happen to telehealth and other waivers when the COVID-19 PHE ends.
This author answers more questions about what will happen to telehealth and other waivers when the COVID-19 PHE ends.
This author answers more...
09/07/2022
Today's Wound Clinic
Business Briefs
The COVID-19 Public Health Emergency Extension Also Applies to Telehealth
08/15/2022
The COVID-19 Public Health Emergency (PHE) is extended through October 13, 2022. Many wound/ulcer management professionals have been using telehealth and should be happy to know that the Medicare waivers pertaining to telehealth have also...
The COVID-19 Public Health Emergency (PHE) is extended through October 13, 2022. Many wound/ulcer management professionals have been using telehealth and should be happy to know that the Medicare waivers pertaining to telehealth have also...
The COVID-19 Public Health...
08/15/2022
Today's Wound Clinic
Business Briefs
The COVID-19 Public Health Emergency, Coding Changes, and Coverage Changes Continue
02/09/2022
For this month, let us review the continuation of the COVID-19 public health emergency (PHE), and the continuation of the ever-changing codes and coverage.
For this month, let us review the continuation of the COVID-19 public health emergency (PHE), and the continuation of the ever-changing codes and coverage.
For this month, let us review...
02/09/2022
Today's Wound Clinic

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use